Respiratory disorders
17 results
Applied filters
Doxycycline for sinusitis
18 March 2026SPS PGD template for the supply of doxycycline for sinusitis in penicillin allergy and where an intranasal steroid is unsuitable or ineffective.
Fluticasone furoate nasal spray for sinusitis
25 March 2026SPS PGD template for the supply of fluticasone furoate nasal spray for sinusitis.
Clarithromycin for sore throat
21 April 2026SPS PGD template for the supply of clarithromycin for sore throat in those with a penicillin allergy.
Amoxicillin for otitis media
28 May 2026SPS PGD template for the supply of amoxicillin for otitis media.
Otigo (phenazone with lidocaine) ear drops for otitis media
3 June 2026SPS PGD template for the supply of Otigo (phenazone with lidocaine) ear drops for symptomatic relief of pain due to otitis media.
SMRs in problematic polypharmacy: respiratory focus
13 January 2026Consultant pharmacists used a case study to illustrate a patient centred approach to SMRs for patients with respiratory conditions.
Mometasone furoate monohydrate nasal spray for sinusitis
25 March 2026SPS PGD template for the supply of mometasone furorate monohydrate nasal spray for sinusitis.
Penicillin V (phenoxymethylpenicillin) for sinusitis
18 March 2026SPS PGD template for the supply of penicillin V (phenoxymethylpenicillin) where an intranasal steroid is unsuitable or ineffective.
Clarithromycin for otitis media
28 May 2026SPS PGD template for the supply of clarithromycin for otitis media in those with a penicillin allergy.
The licence and supporting evidence for omalizumab biosimilar
20 July 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. Review its indications, evidence, and main differences.